02-26-19: Gene-Therapy Stocks Surge On Speculation Of Renewed M&A Potential

InvestTalk

Hosts Justin Klein & Luke Guerrero, CFA | Wealth Managers and Investment Advisors

Business, News, News Commentary, Entrepreneurship, Investing, Business News

4.4 • 1.5K Ratings

🗓️ 27 February 2019

⏱️ 25 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Shares of gene-therapy companies surged Monday, boosted by the news of Roche Holding AG’s acquisition of Spark Therapeutics Inc.

Today's Stocks & Topics: Banks Investing, GFF - Griffon Corp., XLF - Financial Select Sector SPDR ETF, Buying Dips, PXD - Pioneer Natural Resources Co., BGS - B&G Foods Inc., Mutual Funds, ARCC - Ares Capital Corp., Home Price Growth.

Our Sponsors: * Check out Anthropic and use my code Claude.ai/invest for a great deal: https://www.anthropic.com * Check out Chilipad and use my code sleep.me/INVEST for a great deal: https://sleep.me * Check out Plaud AI and use my code INVEST for a great deal: https://plaud.ai * Check out Progressive: https://www.progressive.com * Check out Quince and use my code quince.com/invest for a great deal: https://www.quince.com * Check out Scribe and use my code scribe.how/invest for a great deal: https://scribe.com * Check out TaskRabbit and use my code INVEST for a great deal: https://taskrabbit.com * Check out TruDiagnostic and use my code INVEST20 for a great deal: https://www.trudiagnostic.com Advertising Inquiries: https://redcircle.com/brands

Transcript

Click on a timestamp to play from that location

0:00.0	Steve and justin use why charts for their winning investment research
0:04.6	so start your free trial now and if you purchase mention invest talk and get a generous
0:10.4	discount at whyCharts.com. This podcast is produced by KPP Financial, Steve
0:19.3	Peasley President, KPP Financial, Independent Thinking, shared success.
0:26.3	And now today's podcast.
0:27.8	889 chart. Our main talking point today is gene therapy stock surge on speculation of
0:37.6	renewed merger and acquisition potential and why do they think that's potential
0:42.8	out there?
0:43.8	It's because Roche Holdings AG acquired Spark therapeutics.
0:48.8	120% of their, 120% of their public price. So they paid 20% more than the stock was trading that.
0:58.0	And the question is, is that, the reason why they're all surging is because people think that if well if one was purchased
1:05.8	maybe others will be bought.
1:08.0	Well that's a possibility but I don't think you should bet on it. I don't think that's how you should invest
1:15.6	You should invest because the biotechnology stock has good good fundamentals
1:21.1	Therefore and if it gets bought it gets bought, it gets bought.
1:23.4	If it doesn't, it doesn't.
1:24.7	You buy stocks because they have good fundamentals.
1:28.4	They have earnings.
1:29.4	They have growth of earnings.
1:30.4	They have, you know, don't buy story stock.
1:33.4	How many people go out and buy, oh, this stock, I mean, 20, 30 years ago,
1:38.6	everybody bought these biotech stocks because they would have a next cure for cancer.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Hosts Justin Klein & Luke Guerrero, CFA | Wealth Managers and Investment Advisors, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Hosts Justin Klein & Luke Guerrero, CFA | Wealth Managers and Investment Advisors and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.